Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy.
Cancers (Basel)
; 16(9)2024 Apr 29.
Article
in En
| MEDLINE
| ID: mdl-38730688
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancers (Basel)
Year:
2024
Document type:
Article
Affiliation country:
España
Country of publication:
Suiza